Skip to main content
Watch Insiders
CGEMHealthcare

Cullinan Therapeutics Inc (CGEM) Insider Trading

In the last 90 days, 1 Cullinan Therapeutics Inc (CGEM) insider reported no open-market purchases and 2 sales totaling $780,360. Source: SEC Form 4 filings.

SEC-reported filing activity is provided for research purposes and is not investment advice.

90-day C-suite buyers
0
90-day purchase value
$0.00
Corporate buyers
0
Latest transaction
Sep 8, 2026

Executive filings

Open-market transaction history

Purchase and sale summaries are ordered by the latest reported transaction date.

Open-market insider purchase and sale transactions
DateInsider nameRoleTypeSharesPriceTotal value
Sep 8, 2026Jennifer MichaelsonChief Scientific OfficerSale8,000$21.57$172,560
Aug 13, 2026Jennifer MichaelsonChief Scientific OfficerSale30,000$20.26$607,800
Jul 6, 2026Jennifer MichaelsonChief Scientific OfficerSale8,000$17.82$142,560
May 5, 2026Jennifer MichaelsonChief Scientific OfficerSale8,000$14.62$116,996

Common questions

CGEM insider trading FAQ

Are CGEM insiders buying or selling?
Over the last 90 days, CGEM insiders were net sellers, reporting $0.00 of open-market purchases and $780,360 of sales.
When was the last CGEM insider purchase?
No open-market insider purchase of Cullinan Therapeutics Inc stock was reported in the last 90 days.
Where does CGEM insider trading data come from?
Watch Insiders reads the SEC Form 4 filings that Cullinan Therapeutics Inc officers, directors, and 10% owners submit to EDGAR, and refreshes this page daily.